PET-CT Scanner Devices Market Size,Challenges,Growth, Future Potential Of Industry 2023

According to a new report released by Allied Market Research, PET-CT Scanner Devices Market by Application, Service Provider, Type, Number of Slices and Isotopes: Global Opportunity Analysis and Industry Forecast, 2017-2023, of the Global PET-CT Scanner Devices Market. Its value was $1,454 million in 2016, and is expected to reach $2,108 million in 2023 and is expected to grow at an annual average of 5% from 2017 to 2023. The oncology segment accounted for over 5/6 of the total market share in 2016.

Click Here to Access Free Sample Report: https://www.alliedmarketresearch.com/request-sample/4422

Many diseases, such as cancer, cardiovascular, certain infections, and brain diseases, require both positron emission tomography (PET) and computed tomography (CT) scans for proper diagnosis of the disease. PET scanners measure metabolic activity, whereas CT scanners highlight the anatomy of the body. PET-CT scanners combine the advantages of both scanners to enable more accurate diagnosis, as well as localization and monitoring of disease. It also reduces space in the imaging facility and reduces the time it takes doctors to increase scans.

know more: https://www.alliedmarketresearch.com/pet-ct-scanner-device-market

According to the application, the oncology segment had the highest market share in 2016, with increasing cancer incidence worldwide. On the basis of service providers, the hospital segment recorded the highest market share in 2016 due to the growing number of hospitals and the pool of skilled workers available in the hospital. By type, the market is segmented into the fixed scanner segment, with the highest market share in 2016 due to the high cost and reliability of the device. Based on the number of slices, the middle slice scanner (64 slices) scanner segment had the highest market share in 2016 due to its high utilization rate.

The isotope-based Flurodeoxyglucose (FDG) segment has the highest market share in 2016, applying detection of various diseases such as oncology, cardiology and neurology.

The Asia-Pacific region accounted for more than 2/5 of the share in 2016 and is expected to dominate the market during the forecast period, due to increased costs of medical system upgrades and increased demand for technologically advanced devices. In addition, profitable growth opportunities in emerging economies are expected to provide new growth opportunities for key players in the market. In addition, the Asia Pacific region is estimated to have experienced the highest growth during the forecast period due to increased government healthcare spending, increased demand for medical devices from a large patient population, and improved healthcare infrastructure.

Purchase Inquiry: https://www.alliedmarketresearch.com/purchase-enquiry/4422

Key Results of the PET-CT Scanner Devices Market:
• By application, the oncology sector dominated the market in 2016 and is expected to grow to the highest CAGR.
• By service provider, the hospital sector accounted for the highest share in 2016.
• By type, the stationary scanner segment is expected to grow at the highest CAGR.
• Medium slice scanners (64 slices) held the highest share in 2016 by number of slices.
• On an isotope basis, FDG held the 8-9th highest market share in 2016.
• The US was a major shareholder in the North American PET-CT scanner device market in 2016.
• Asia Pacific region is expected to have the highest market share and highest growth rate during the analysis period.
• India is expected to grow at the highest CAGR in the Asia Pacific market.

Leading companies operating in this market adopt product launch as their primary development strategy. Companies profiled in this market include Toshiba Corporation, General Electric Co, Hitachi, Ltd., Koninklijke Philips N.V., Shimadzu Corporation, Siemens AG, PerkinElmer, Inc., Positron Corporation, Yangzhou Kindsway Biotech Co. Ltd. And Mediso Ltd.

Other major players in the value chain include NeuroLogica Corporation, NaturSoft Medical Systems Co., Ltd., Shenzhen Anke High-Tech, Trivitron Technologies and Shenzhen Anke High-tech Co.

Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web:https://www.alliedmarketresearch.com
Follow Us on LinkedIn:https://www.linkedin.com/company/allied-market-research

About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

This release was published on openPR.